Sponsor or institution
Clinical trials and research at Beam Therapeutics Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Beam Therapeutics Inc. that are recruiting, at sites in 6 countries (most in United States (3), United Kingdom (2), Australia (1)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term follow-up after BEAM-101 treatment | — | Birmingham, Alabama and 16 other locations | Recruiting | Jan 28, 2026 |
| Phase 1 randomized single‑blind placebo‑controlled safety and dosing of BEAM‑103 in healthy adults | Phase 1 | London | Recruiting | Dec 26, 2025 |
| Evaluating BEAM-301 for treating Glycogen Storage Disease Type Ia | Phase 1/2 | Orange, California and 2 other locations | Recruiting | Dec 16, 2024 |
| Evaluating BEAM-302 for treating Alpha-1 Antitrypsin Deficiency in adults | Phase 1/2 | Birmingham, Alabama and 11 other locations | Recruiting | Apr 29, 2024 |
All recruiting trials (4)
-
Long-term follow-up after BEAM-101 treatment
This follow-up will see how people with sickle cell disease who received BEAM-101 are doing over 15 years.
-
Phase 1 randomized single‑blind placebo‑controlled safety and dosing of BEAM‑103 in healthy adults
This study will test a single intravenous dose of BEAM‑103 versus placebo in healthy adults 18–55 to see how safe it is and how the body processes the drug.
-
Evaluating BEAM-301 for treating Glycogen Storage Disease Type Ia
This study is testing a new treatment called BEAM-301 to see if it is safe and effective for adults with Glycogen Storage Disease Type Ia who have a specific genetic variant.
-
Evaluating BEAM-302 for treating Alpha-1 Antitrypsin Deficiency in adults
This study is testing a new treatment called BEAM-302 to see if it can help adults with Alpha-1 Antitrypsin Deficiency who have lung or liver problems.
Quick answers
How many clinical trials run by Beam Therapeutics Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), United Kingdom (2 trials), Australia (1 trial), Ireland (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.